Preventing Dystonic Cerebral Palsy by Adjusting Brain Cell Activity
Modulation of striatal cholinergic interneuron activity to prevent dystonic cerebral palsy
This project explores if boosting specific brain cell activity in young brains can stop dystonic cerebral palsy from developing after a brain injury.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11122199 on NIH RePORTER |
What this research studies
Dystonic cerebral palsy (CP) is a common and often debilitating form of childhood dystonia that currently lacks effective treatments. This research uses a specialized mouse model that mimics how dystonia develops in children after a brain injury. We are focusing on specific brain cells, called cholinergic interneurons, to understand if increasing their activity in the developing brain could prevent dystonia. The aim is to identify early interventions during the period between brain injury and the onset of dystonia symptoms.
Who could benefit from this research
Good fit: This foundational work is aimed at understanding the mechanisms of dystonic cerebral palsy in children who have experienced neonatal brain injury.
Not a fit: Patients whose dystonia is not related to neonatal brain injury or the specific brain cell activity being studied may not directly benefit from this particular approach.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that prevent dystonic cerebral palsy from developing in children who have experienced neonatal brain injury.
How similar studies have performed: While dystonia is often studied in genetic models, this approach specifically targets dystonic cerebral palsy following neonatal brain injury, making the exact intervention novel in this context.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Aravamuthan, Bhooma — Washington University
- Study coordinator: Aravamuthan, Bhooma
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.